Bliss GVS Pharma Limited (NSE:BLISSGVS)
India
· Delayed Price · Currency is INR 116.42
-2.19 (-1.85%)
Mar 12, 2025, 3:29 PM IST
Bliss GVS Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 12, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 12,270 | 11,793 | 7,421 | 7,978 | 10,181 | 10,397 | Upgrade
|
| Market Cap Growth | 33.41% | 58.92% | -6.98% | -21.63% | -2.08% | -43.98% | Upgrade
|
| Enterprise Value | 11,395 | 11,487 | 7,314 | 7,890 | 10,302 | 10,430 | Upgrade
|
| Last Close Price | 116.42 | 112.36 | 70.39 | 75.76 | 96.40 | 98.23 | Upgrade
|
| PE Ratio | 20.58 | 15.63 | 10.47 | 53.04 | 14.86 | 10.69 | Upgrade
|
| PS Ratio | 2.14 | 1.53 | 0.99 | 1.07 | 1.76 | 1.51 | Upgrade
|
| PB Ratio | 1.66 | 1.18 | 0.81 | 0.94 | 1.23 | 1.39 | Upgrade
|
| P/TBV Ratio | 1.73 | 1.23 | 0.85 | 0.98 | 1.27 | 1.43 | Upgrade
|
| P/FCF Ratio | - | 9.50 | - | 12.98 | 18.56 | - | Upgrade
|
| P/OCF Ratio | - | 7.74 | 21.63 | 5.89 | 15.91 | 22.26 | Upgrade
|
| EV/Sales Ratio | 1.41 | 1.49 | 0.97 | 1.06 | 1.78 | 1.51 | Upgrade
|
| EV/EBITDA Ratio | 8.34 | 7.77 | 6.31 | 6.77 | 9.88 | 8.60 | Upgrade
|
| EV/EBIT Ratio | 10.78 | 9.25 | 7.41 | 7.79 | 11.52 | 9.38 | Upgrade
|
| EV/FCF Ratio | - | 9.26 | - | 12.83 | 18.78 | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.10 | 0.11 | 0.13 | 0.15 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.69 | 0.66 | 0.87 | 0.92 | 1.14 | 1.02 | Upgrade
|
| Debt / FCF Ratio | - | 0.80 | - | 1.78 | 2.22 | - | Upgrade
|
| Asset Turnover | - | 0.65 | 0.66 | 0.68 | 0.55 | 0.71 | Upgrade
|
| Inventory Turnover | - | 3.62 | 3.64 | 3.62 | 3.90 | 5.90 | Upgrade
|
| Quick Ratio | - | 3.49 | 2.38 | 2.32 | 2.66 | 2.66 | Upgrade
|
| Current Ratio | - | 5.08 | 3.61 | 3.33 | 3.76 | 3.34 | Upgrade
|
| Return on Equity (ROE) | - | 8.50% | 8.70% | 2.76% | 9.37% | 13.51% | Upgrade
|
| Return on Assets (ROA) | - | 6.55% | 5.44% | 5.79% | 5.31% | 7.19% | Upgrade
|
| Return on Capital (ROIC) | 5.99% | 7.32% | 6.24% | 6.65% | 6.12% | 8.48% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 11.79% | 10.24% | 11.57% | 10.24% | 13.95% | Upgrade
|
| Earnings Yield | 4.86% | 6.40% | 9.55% | 1.89% | 6.73% | 9.35% | Upgrade
|
| FCF Yield | 10.52% | -8.02% | 7.71% | 5.39% | -1.21% | Upgrade
| |
| Dividend Yield | 0.43% | 0.45% | 0.71% | 0.66% | 0.52% | 0.51% | Upgrade
|
| Payout Ratio | 0.00% | 7.15% | 7.67% | 35.41% | 8.10% | 12.85% | Upgrade
|
| Buyback Yield / Dilution | -0.07% | -0.56% | -0.26% | 0.26% | -2.26% | - | Upgrade
|
| Total Shareholder Return | 0.36% | -0.12% | 0.45% | 0.92% | -1.74% | 0.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.